Literature DB >> 25559357

Risk factors for poor neonatal adaptation after exposure to antidepressants in utero.

Noera Kieviet1, Chris Hoppenbrouwers, Koert M Dolman, Johannes Berkhof, Hanneke Wennink, Adriaan Honig.   

Abstract

AIM: Infants exposed to antidepressants in utero are at risk of developing poor neonatal adaptation (PNA). This study identified risk factors for PNA.
METHODS: In this cohort study, data on mothers and infants admitted to the maternity ward of a general hospital between 2007 and 2012 were analysed. All infants were exposed to an antidepressant during the last trimester of foetal life. The main outcome measure was PNA, defined as at least one Finnegan scores of four or more during admission. Risk factors analysed for their possible association with PNA included type of feeding, type and dosage of antidepressant, prematurity and maternal smoking, anxiety and depression.
RESULTS: We included 247 infants in the study and 157 (64%) developed PNA. Formula feeding was associated with an increased risk of PNA compared to breastfeeding or mixed feeding (OR 3.16 95% CI 1.40-7.13 p = 0.003). Selective serotonin reuptake inhibitors (SSRIs) were associated with an increased risk of PNA compared to serotonin and noradrenaline reuptake inhibitors (OR 2.52 95% CI 1.07-5.95 p = 0.04). Dosage did not influence the risk of PNA (OR 1.50 95% CI 0.89-2.52 p = 0.13).
CONCLUSION: Formula feeding and exposure to SSRIs were associated with development of PNA, but dosage was not. ©2015 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Antidepressants; Neonatal abstinence; Poor neonatal adaptation; Serotonin reuptake inhibitors

Mesh:

Substances:

Year:  2015        PMID: 25559357     DOI: 10.1111/apa.12921

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates.

Authors:  Amy Yang; Jody D Ciolino; Emily Pinheiro; Laura J Rasmussen-Torvik; Dorothy K Y Sit; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2017-05       Impact factor: 4.384

2.  Use of antidepressants during pregnancy in the Netherlands: observational study into postpartum interventions.

Authors:  Noera Kieviet; Fokke de Jong; Fedde Scheele; Koert M Dolman; Adriaan Honig
Journal:  BMC Pregnancy Childbirth       Date:  2017-01-11       Impact factor: 3.007

3.  Respiratory depression in a neonate born to mother on maximum dose sertraline: a case report.

Authors:  Greg J Marchand; Katerina Meassick; Hannah Wolf; Sophia K Hopewell; Katelyn Sainz; Sienna M Anderson; Kelly Ware; Janelle Vallejo; Alexa King; Stacy Ruther; Giovanna Brazil; Kaitlynne Cieminski; Nicolas Calteux
Journal:  J Med Case Rep       Date:  2021-02-19

4.  Variation in the management of SSRI-exposed babies across England.

Authors:  Eliza Thomas; Phil J Peacock; Sarah E Bates
Journal:  BMJ Paediatr Open       Date:  2017-08-11

5.  Effect of Depressive Disorders and Their Pharmacological Treatment during Pregnancy on Maternal and Neonatal Outcome.

Authors:  Giulia Parpinel; Gianluca Rosso; Arianna Galante; Chiara Germano; Elena Aragno; Flavia Girlando; Alessandro Messina; Maria Elena Laudani; Alessandro Rolfo; Rossella Attini; Alberto Revelli; Giuseppe Maina; Bianca Masturzo
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.